DMTK
Price
$0.71
Change
+$0.06 (+9.23%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
HAE
Price
$84.16
Change
+$2.53 (+3.10%)
Updated
Mar 27, 6:59 PM EST
40 days until earnings call
Ad is loading...

DMTK vs HAE ᐉ Comparison: Which is Better to Invest?

Header iconDMTK vs HAE Comparison
Open Charts DMTK vs HAEBanner chart's image
DermTech
Price$0.71
Change+$0.06 (+9.23%)
Volume$334.73K
CapitalizationN/A
Haemonetics
Price$84.16
Change+$2.53 (+3.10%)
Volume$71.09K
CapitalizationN/A
View a ticker or compare two or three
DMTK vs HAE Comparison Chart

Loading...

DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DMTK vs. HAE commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMTK is a Hold and HAE is a Buy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (DMTK: $0.69 vs. HAE: $84.09)
Brand notoriety: DMTK and HAE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DMTK: 128% vs. HAE: 61%
Market capitalization -- DMTK: $24.06M vs. HAE: $4.27B
DMTK [@Medical Specialties] is valued at $24.06M. HAE’s [@Medical Specialties] market capitalization is $4.27B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMTK’s FA Score shows that 0 FA rating(s) are green whileHAE’s FA Score has 0 green FA rating(s).

  • DMTK’s FA Score: 0 green, 5 red.
  • HAE’s FA Score: 0 green, 5 red.
According to our system of comparison, DMTK is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMTK’s TA Score shows that 5 TA indicator(s) are bullish while HAE’s TA Score has 6 bullish TA indicator(s).

  • DMTK’s TA Score: 5 bullish, 3 bearish.
  • HAE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DMTK is a better buy in the short-term than HAE.

Price Growth

DMTK (@Medical Specialties) experienced а +0.58% price change this week, while HAE (@Medical Specialties) price change was +5.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.09%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +3.80%.

Reported Earning Dates

DMTK is expected to report earnings on May 01, 2024.

HAE is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (+1.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for DMTK with price predictions.
OPEN
A.I.dvisor published
a Summary for HAE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HAE($4.27B) has a higher market cap than DMTK($24.1M). HAE YTD gains are higher at: -1.661 vs. DMTK (-60.286). HAE has higher annual earnings (EBITDA): 264M vs. DMTK (-97.89M). HAE has more cash in the bank: 194M vs. DMTK (55.9M). DMTK has less debt than HAE: DMTK (54.4M) vs HAE (871M). HAE has higher revenues than DMTK: HAE (1.27B) vs DMTK (15.3M).
DMTKHAEDMTK / HAE
Capitalization24.1M4.27B1%
EBITDA-97.89M264M-37%
Gain YTD-60.286-1.6613,630%
P/E RatioN/A34.18-
Revenue15.3M1.27B1%
Total Cash55.9M194M29%
Total Debt54.4M871M6%
FUNDAMENTALS RATINGS
DMTK vs HAE: Fundamental Ratings
DMTK
HAE
OUTLOOK RATING
1..100
5014
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9859
PRICE GROWTH RATING
1..100
9651
P/E GROWTH RATING
1..100
5080
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (77) in the Medical Specialties industry is in the same range as DMTK (96) in the null industry. This means that HAE’s stock grew similarly to DMTK’s over the last 12 months.

HAE's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as DMTK (100) in the null industry. This means that HAE’s stock grew similarly to DMTK’s over the last 12 months.

HAE's SMR Rating (59) in the Medical Specialties industry is somewhat better than the same rating for DMTK (98) in the null industry. This means that HAE’s stock grew somewhat faster than DMTK’s over the last 12 months.

HAE's Price Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for DMTK (96) in the null industry. This means that HAE’s stock grew somewhat faster than DMTK’s over the last 12 months.

DMTK's P/E Growth Rating (50) in the null industry is in the same range as HAE (80) in the Medical Specialties industry. This means that DMTK’s stock grew similarly to HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMTKHAE
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 13 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UMDD27.951.24
+4.62%
ProShares UltraPro MidCap400
AIVL101.481.32
+1.32%
WisdomTree US Al Enhanced Val ETF
SPYX42.790.36
+0.85%
SPDR® S&P 500 Fossil Fuel Rsrv Free ETF
FNGD36.220.07
+0.19%
MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN
KSET0.88N/A
N/A
KraneShares Global Carbon Offset Str ETF

DMTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMTK has been loosely correlated with SRTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DMTK jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMTK
1D Price
Change %
DMTK100%
+6.92%
SRTS - DMTK
34%
Loosely correlated
-2.01%
BIO - DMTK
31%
Poorly correlated
+2.65%
MASS - DMTK
29%
Poorly correlated
+5.30%
ME - DMTK
28%
Poorly correlated
+5.82%
MYGN - DMTK
28%
Poorly correlated
-0.37%
More

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with LIVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+3.00%
LIVN - HAE
42%
Loosely correlated
+2.68%
STE - HAE
39%
Loosely correlated
+1.81%
INSP - HAE
39%
Loosely correlated
+2.51%
GMED - HAE
37%
Loosely correlated
+2.79%
WAT - HAE
37%
Loosely correlated
+2.10%
More